MedPath

Tonsillectomy Using BiZact Tonsilletomy Device

Not Applicable
Conditions
Tonsillectomy
Registration Number
NCT04320095
Lead Sponsor
University of Calgary
Brief Summary

The purpose of this study is to describe how Bizact Tonsillectomy Device might affect operative time and intraoperative blood loss in pediatric patients undergoing tonsillectomy, and compare these parameters to the standard technique in tonsillectomy at our institution, which is electrocautery.

Detailed Description

It is a prospective, interventional, single-center study on the performance of Bizact tonsillectomy device on children undergoing tonsillectomy.The required parameters concerning operative time and intra operative blood loss will be obtained during the procedure.There will be no extra clinical visits for the participants.

Operative time will be assessed in 2 ways: 1). By using blade-tipped electrocautery on one tonsil and the BiZact device on the other tonsil for same patient; and 2). using electrocautery for removal of both tonsils and comparing the operative time to an equal number of cases wherein the BiZact device was used for removal of both tonsils.

With regard to intra operative bleeding, it will be quantified into one of 3 groups: 1). No blood in suction tubing, 2). blood in suction tubing but not in the suction canister, and 3). blood in the suction canister.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
48
Inclusion Criteria
  1. Children scheduled for tonsillectomy at Alberta Children Hospital
  2. Tonsillectomy for either recurrent tonsillitis or sleep-disordered breathing.
Exclusion Criteria
  1. Craniofacial abnormalities
  2. Bleeding disorders
  3. Complex medical background

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Operative timeduring the procedure

The study will be considered success if the mean intra operative time using Bizact device is less than that using electrocautery

Secondary Outcome Measures
NameTimeMethod
Intraoperative blood lossduring the procedure

The study will be considered success if the mean intraoperative blood loss using Bizact is less than Electrocautery

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.